PALMA, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 22.422
AS - Asia 4.927
EU - Europa 3.029
SA - Sud America 794
AF - Africa 65
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 31.248
Nazione #
US - Stati Uniti d'America 22.270
SG - Singapore 3.085
CN - Cina 714
BR - Brasile 661
IT - Italia 657
DE - Germania 560
HK - Hong Kong 517
IE - Irlanda 387
RU - Federazione Russa 271
UA - Ucraina 236
GB - Regno Unito 201
SE - Svezia 183
VN - Vietnam 177
FR - Francia 127
FI - Finlandia 101
IN - India 99
CA - Canada 81
KR - Corea 67
PL - Polonia 65
AT - Austria 59
NL - Olanda 55
AR - Argentina 54
MX - Messico 46
ID - Indonesia 45
BD - Bangladesh 37
ES - Italia 37
ZA - Sudafrica 30
JP - Giappone 29
TR - Turchia 25
CZ - Repubblica Ceca 24
EC - Ecuador 20
IQ - Iraq 18
BE - Belgio 17
CO - Colombia 15
KG - Kirghizistan 13
PY - Paraguay 12
UZ - Uzbekistan 12
IR - Iran 11
KE - Kenya 10
VE - Venezuela 10
PE - Perù 9
PK - Pakistan 9
PT - Portogallo 9
AZ - Azerbaigian 8
CH - Svizzera 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
NP - Nepal 7
BG - Bulgaria 6
CL - Cile 6
EU - Europa 5
IL - Israele 5
KZ - Kazakistan 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
TN - Tunisia 5
AU - Australia 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LB - Libano 4
RO - Romania 4
SA - Arabia Saudita 4
CR - Costa Rica 3
DM - Dominica 3
DZ - Algeria 3
GA - Gabon 3
GR - Grecia 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
PH - Filippine 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
HU - Ungheria 2
KW - Kuwait 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AW - Aruba 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
JM - Giamaica 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
PR - Porto Rico 1
Totale 31.247
Città #
Wilmington 5.269
Woodbridge 5.221
Houston 4.678
Singapore 1.097
Fairfield 804
Chandler 630
Ashburn 606
Hong Kong 514
Ann Arbor 414
Beijing 399
Dublin 352
Seattle 314
Rome 288
Cambridge 283
Medford 271
Santa Clara 215
The Dalles 205
Jacksonville 185
Los Angeles 172
New York 167
Lawrence 122
Buffalo 107
Munich 99
Dearborn 92
Dallas 78
San Diego 74
Chicago 70
Ho Chi Minh City 65
Nuremberg 63
Milan 60
Council Bluffs 58
São Paulo 57
Engelhard 55
London 51
Menlo Park 41
Montreal 40
Moscow 39
Jakarta 38
Pune 36
Brooklyn 33
Salt Lake City 33
Warsaw 32
Lappeenranta 30
Phoenix 30
Redondo Beach 30
Creede 28
Norwalk 27
Frankfurt am Main 26
Toronto 26
St. George 25
Seoul 24
Tokyo 23
Mülheim 22
Brno 21
Denver 20
Rio de Janeiro 20
Vienna 20
Zhengzhou 20
Hanoi 19
Johannesburg 19
Kraków 19
Boston 18
Orem 18
San Francisco 18
Atlanta 17
Brussels 17
Chennai 17
San Mateo 17
Stockholm 17
Elk Grove Village 16
Redwood City 16
Dong Ket 15
Falls Church 15
Mexico City 15
Poplar 15
Boardman 14
Brasília 14
Ankara 13
Center 13
Hangzhou 13
Hefei 13
Helsinki 13
Mumbai 13
Querétaro 13
Tampa 13
Turku 13
Amsterdam 12
Guangzhou 12
Verona 12
Santo André 11
Sterling 11
Barcelona 10
Da Nang 10
Del Norte 10
Genoa 10
Monte Vista 10
Mountain View 10
Nanjing 10
Belo Horizonte 9
Tashkent 9
Totale 24.398
Nome #
Role of individual's T cell immunome in controlling HIV-1 progression 586
Therapeutic DNA Vaccination of Vertically HIV-Infected Children: Report of the First Pediatric Randomised Trial (PEDVAC) 494
A 2-month-old male with pyuria and persistent fever 493
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency 486
B-Sides Serologic Markers of Immunogenicity in Kidney Transplanted Patients 475
Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child 473
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain 472
Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza 471
An atypical case of multifocal infantile haemangioma in a child after Highly Active Antiretroviral Therapy (HAART) during pregnancy 463
Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation 462
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 459
Transitory hypogammaglobulinemia of infancy in FG syndrome [2] 455
Early Highly Active Antiretroviral Therapy Enhances B-cell Longevity 446
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants 445
Visceral leishmaniasis revealing chronic granulomatous diseases in a child 443
Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases 437
Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays 436
. Early-onset monocyte-B-natural killer-dendritic cells’ deficiency successfully treated with hematopoietic stem cell transaplantation 434
Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency 433
Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults 428
Premature aging of the immune system relates with increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1 infected and kidney transplanted patients 428
A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency 420
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children 419
Early antiretroviral therapy in children perinatally infected with HIV: A unique opportunity to implement immunotherapeutic approaches to prolong viral remission 419
The impact of active HIV-1 replication on the physiological age-related decline of immature-transitional B-cells in HIV-1 infected children. 416
HIV is associated with thrombophilia and high D-dimer in children and adolescents 416
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain 413
Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment 408
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 403
B-Sides Serologic Markers of Immunogenicity in Kidney Transplanted Patients: Report From 2012Y2013 Flu Vaccination Experience 398
Serratia marcescens Osteomyelitis in a Newborn with Chronic Granulomatous 395
The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected children 392
Raising awareness of non-hodgkin lymphoma in HIV-infected adolescents: Report of 2 cases in the HAART era 392
Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV 387
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression 385
Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience 383
How should eosinophilic cystitis be treated in patients with chronic granulomatous disease? 378
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children 371
Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis 371
Paediatric HIV infection in Western Africa: the long way to the standard of care 365
Cellular immune profile of kidney transplant patients developing anti-HLA antibodies during childhood 363
Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions 359
Familial Hemophagocytic Lymphohistiocytosis Type 3 Diagnosed at School Age: A Case Report 352
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency 330
Perturbation of B cell gene expression persists in HIV-infected children despite effective antiretroviral therapy and predicts H1N1 response 328
Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses 322
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 316
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. 298
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 294
The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection 210
Secondary cytomegalovirus infections: How much do we still not know? Comparison of children with symptomatic congenital cytomegalovirus born to mothers with primary and secondary infection 208
Faster Initial Viral Decay in Female Children Living with HIV 207
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 204
High dimensional cytokine panels reveal common SARS-CoV-2-related inflammation patterns across different latitudes 202
Pediatric routine vaccinations in the COVID 19 lockdown period: the survey of the Italian Pediatric Society 200
Characterization of T and B cell repertoire diversity in patients with RAG deficiency 197
null 192
Corrigendum : Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies (Frontiers in Immunology (2019) 10 (316) DOI: 10.3389/fimmu.2019.00316) 179
Next-Generation Sequencing Reveals A JAGN1 Mutation in a Syndromic Child with Intermittent Neutropenia 175
Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers 175
Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment. 173
Waning of vaccine-induced immunity to measles in kidney transplanted children 172
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 167
Immunotherapy with an HIV-DNA vaccine in children and adults 167
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 160
Prolonged impairment of immunological memory after Anti-CD20 treatment in pediatric idiopathic nephrotic syndrome 159
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 157
Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission 152
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. 152
Human Immunodeficiency Virus (HIV)-Antibody repertoire estimates reservoir size and time of antiretroviral therapy initiation in virally suppressed perinatally HIV-infected children 151
How to dissect the plasticity of antigen specific immune response: a tissue perspective 144
Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy 142
Early ART-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T and B cell memory 139
Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy 136
The mission is remission: Hope for controlling HIV replication without ART in early-treated perinatally HIV-infected children 120
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 117
Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene 113
Premature B-cell senescence as a consequence of chronic immune activation: Implications for vaccination of immune compromised individuals 111
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 109
Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome 101
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 97
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 97
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial 96
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 91
OMIC Technologies and vaccine development: From the identification of vulnerable individuals to the formulation of invulnerable vaccines 89
Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up 89
Case Report: Two Cases of Pediatric Thrombotic Thrombocytopenic Purpura Treated With Combined Therapy 89
The second generation of HIV-1 vertically exposed infants: A case series from the Italian Register for paediatric HIV infection 87
Induction of il21 in peripheral t follicular helper cells is an indicator of influenza vaccine response in a previously vaccinated HIV-infected pediatric cohort 84
COVID-19 in children: From afterthought to unknown 84
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 83
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 82
Mild SARS-CoV-2 infections and neutralizing antibody titers 81
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital 80
Targeted treatment of autoimmune cytopenias in primary immunodeficiencies 78
T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals 78
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults 78
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome 77
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens 76
Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth 76
Totale 26.895
Categoria #
all - tutte 104.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.451


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.913 0 0 0 0 0 462 498 453 137 155 128 80
2021/20221.589 50 132 72 49 270 109 23 55 228 76 129 396
2022/20231.819 159 149 42 186 134 411 239 117 220 8 99 55
2023/2024901 70 107 39 18 85 231 57 37 24 25 88 120
2024/20255.452 135 927 427 271 116 375 270 265 446 417 1.036 767
2025/20263.477 631 433 825 688 664 236 0 0 0 0 0 0
Totale 31.871